Global Pharmaceuticals & Medicine Manufacturing
Over the five years to 2019, pharmaceutical manufacturers have benefited from an aging population in developed economies and a growing middle class in emerging economies, which provided a larger customer base for operators in the Global Pharmaceuticals and Medicine Manufacturing industry. Many manufacturers also tapped into regional demand for pharmaceuticals that may differ from developed markets. Furthermore, the growing global middle class provides additional growth opportunities, given increased access to pharmaceutical products and higher per capita expenditure on medicines. Many manufacturers expanded their global presence to tap into regional market needs and develop relationships with government entities that can accelerate drug approval or implement high reimbursement rates. Nevertheless, patent cliffs have continued to hamper industry revenue. When blockbuster drugs lose patent exclusivity, the market is inundated with low-cost generic drugs. Over the five years to 2024, industry revenue is forecast to grow amid an anticipated persistence of global economic health.
The industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms, including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based, or ethical products, and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Global Pharmaceuticals & Medicine Manufacturing
Over the five years to 2019, pharmaceutical manufacturers have benefited from an aging population in developed economies and a growing middle class in emerging economies, which provided a larger customer base for operators in the Global Pharmaceuticals and Medicine Manufacturing industry. Many manufacturers also tapped into regional demand for pharmaceuticals that may differ from developed markets. Furthermore, the growing global middle class provides additional growth opportunities, given increased access to pharmaceutical products and higher per capita expenditure on medicines. Many manufacturers expanded their global presence to tap into regional market needs and develop relationships with government entities that can accelerate drug approval or implement high reimbursement rates. Nevertheless, patent cliffs have continued to hamper industry revenue. When blockbuster drugs lose patent exclusivity, the market is inundated with low-cost generic drugs. Over the five years to 2024, industry revenue is forecast to grow amid an anticipated persistence of global economic health.
The industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms, including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based, or ethical products, and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
LOADING...
